Graphium biosciences inc
Web4.4K 52-Wk Range 0.1201 - 0.2986 (04/28/22 - 10/11/22) 33.22% Historical Volatility 149.3% Market Cap 12.5M Shares Outstanding 78.1M EPS (TTM, GAAP) -0.03 P/E Ratio (TTM, GAAP) -- Annual Dividend/Yield No dividend Ex-dividend Date No dividend Dividend Pay Date No dividend Beta 2.6 % Held by Institutions 0.10 Short Interest -- Web--MALACHITE INNOVATIONS, INC. announces that its wholly-owned drug development subsidiary, Graphium Biosciences, Inc., has been granted two patents by the U.S. …
Graphium biosciences inc
Did you know?
WebOct 12, 2024 · Graphium Biosciences, our operating subsidiary dedicated to improving the health and wellness of people, seeks to advance our broad portfolio of over 100 novel … cleveland, ohio, may 13, 2024 (globe newswire) -- malachite innovations, inc. … GlobeNewswire specializes in the distribution and delivery of press … CLEVELAND, OHIO, Dec. 28, 2024 (GLOBE NEWSWIRE) -- MALACHITE … GlobeNewswire specializes in the distribution and delivery of press … June 26, 2024 11:00 ET Source: SPR Therapeutics, Inc. CLEVELAND, June … February 24, 2024 18:46 ET Source: We The Patriots USA, Inc. AKRON, Ohio, … WebSep 22, 2016 - Graphium Biosciences, Inc. The present invention relates to cannabinoid glycoside prodrugs suitable for site- and tissue-specific delivery of cannabinoid molecules. The present invention also relates to methods of forming the cannabinoid glycoside prodrugs through glycosyltransferase mediated glycosylation of cannabinoid molecules.
WebSince we were founded in 1989, we've focused on providing innovative solutions for education and business. Get in touch. 45190 Prologis Plaza, Suite 165. Dulles , VA … WebGraphium Biosciences, our operating subsidiary dedicated to improving the health and wellness of people, seeks to advance our broad portfolio of over 100 novel cannabinoid …
WebMay 13, 2024 · We now have the requisite capital to further advance our ESG-centric mission of creating a market-leading environmental services business that improves the health and wellness of our planet, with a... WebApr 6, 2024 · Malachite Innovations, Inc. FY 2024 revenue was $4.8 million compared to $0 of revenue reported for the four calendar yea... Malachite Innovations FY22 Revenue Grows To $4.8M, Achieving More Than Its Total Revenue Over Its Previous 10 Years Of …
WebAvidity Biosciences, Inc. San Diego Metropolitan Area 10 minutes ago Be among the first 25 applicants See who Avidity Biosciences, Inc. has hired for this role
WebInvestors. Graphium Biosciences. News and Events. 2024 ANNUAL REPORT HIGHLIGHTS. CLEVELAND, OHIO – (April 5, 2024) – MALACHITE INNOVATIONS, … orchestrion repairs in southern californiaorchestrion zlešiceWebDec 28, 2024 · Graphium Biosciences, our operating subsidiary dedicated to improving the health and wellness of people, seeks to advance our broad portfolio of over 100 novel … ipx7 rating explainedWebDec 28, 2024 · Graphium Biosciences, our operating subsidiary dedicated to improving the health and wellness of people, seeks to advance our broad portfolio of over 100 novel … ipx7 headphones runningWebGraphium Biosciences, Inc. is a cannabinoid-based drug development company tracing its history of technological innovation and drug advancement back to October 2011 through two predecessor ... orchestrion musikWebApr 1, 2024 · Its Graphium Biosciences, Inc. is focused on advancing its portfolio of over 100 cannabinoid-glycoside compounds created using its enzymatic bioprocessing technologies to develop treatments for chronic and debilitating conditions. The Daedalus Ecosciences, Inc. (Daedalus). is focused on the health and wellness through … orchestrion repairs near meWebApr 6, 2024 · Graphium Biosciences, Inc. is a cannabinoid-based drug development company tracing its history of technological innovation and drug advancement back to … ipx7 protection